Filter Search for grants
Program navigation
Program key data
Horizon Europe: Cluster 1 - Health
Parent program | Horizon Europe |
Link to the program | ec.europa.eu |
Content of program
short description | Cluster 1 "Health" of the Horizon Europe program includes many topics from health research. Projects cover the entire spectrum of the research and innovation cycle as far as possible and should also contribute to the implementation of research results in healthcare. |
program objectives | The aims of this cluster include improving and protecting the health and well-being of citizens of all ages by generating new knowledge, developing innovative solutions and integrating where relevant a gender perspective to prevent, diagnose, monitor, treat and cure diseases. Further aims include developing health technologies, mitigating health risks, protecting populations and promoting good health and well-being in general and at work. Finally, this cluster also aims to make public health systems more cost-effective, equitable and sustainable, prevent and tackle poverty-related diseases and support and enable patients' participation and self-management. Areas of intervention
Destination 1 "Staying healthy in a rapidly changing society" will focus on major societal challenges that are part of the European Commission’s political priorities, notably diet and health (obesity), ageing and demographic change, mental health, digital empowerment in health literacy, and personalised prevention. Destination 2 "Living and working in a health-promoting environment" aims at filling knowledge gaps in the understanding of the impacts on our health and well-being of those environmental, occupational and socio-economic risk factors that have the most significant or widespread societal impacts. Destination 3 "Tackling diseases and reducing disease burden" will focus on major societal challenges linked to the Commission’s political priorities such as the fight against cancer and other non-communicable diseases, better diagnosis and treatment of rare diseases, preparedness and response to and surveillance of health threats and epidemics, reduction of the number of antimicrobial-resistant infections, improving vaccination rates, demographic change, mental health and digital empowerment in health literacy. Under destination 4 "Ensuring access to innovative, sustainable and high-quality health care", research and innovation aims at supporting health care systems in their transformation to ensure fair access to sustainable health care services of high quality for all citizens. Funded activities should support the development of innovative, feasible, implementable, financially sound and scalable solutions in the various dimensions of health care systems (e.g. governance, financing, human and physical resources, health service provision, and patient empowerment). Destination 5 "Unlocking the full potential of new tools, technologies and digital solutions for a healthy society" aims to promote the development of tools, technologies and digital solutions for treatments, medicines, medical devices and improved health outcomes, taking into consideration safety, effectiveness, appropriateness, accessibility, comparative value-added and fiscal sustainability as well as issues of ethical, legal and regulatory nature. In order to address in particular green and digital transitions and proper supply of health technologies and products, destination 6 "Maintaining an innovative, sustainable and globally competitive health industry" will focus on research and innovation activities that aim at:
read more |
Expected effects and impacts | Destination 1: Proposals for topics under this destination should set out a credible pathway to contributing to staying healthy in a rapidly changing society, and more specifically to one or several of the following impacts:
Destination 2: Proposals for topics under this destination should set out a credible pathway to contributing to living and working in a health-promoting environment, and more specifically to one or several of the following impacts:
Destination 3: Proposals for topics under this destination should set out a credible pathway to contributing to tackling diseases and reducing disease burden, and more specifically to several of the following impacts:
The EU benefits from high visibility, leadership and standing in international fora on global health and global health security, especially in partnership with Africa. Destination 4: Proposals for topics under this destination should set out a credible pathway to contributing to ensuring access to innovative, sustainable and high-quality health care, and more specifically to one or several of the following impacts:
Destination 5: Proposals for topics under this destination should set out a credible pathway towards unlocking the full potential of new tools, technologies and digital solutions for a healthy society, and more specifically to several of the following expected impacts:
Destination 6: Proposals for topics under this destination should set out a credible pathway to contributing to maintaining an innovative, sustainable and globally competitive health industry, and more specifically to one or several of the following expected impacts:
read more |
Eligibility criteria
Regions / countries for funding | EU Member States, Overseas Countries and Territories (OCT) Moldova (Moldova), Albania (Shqipëria), Armenia (Հայաստան), Bosnia and Herzegovina (Bosna i Hercegovina / Босна и Херцеговина), Canada, Faeroes (Føroyar / Færøerne), Georgia (საქართველო), Iceland (Ísland), Israel (ישראל / إِسْرَائِيل), Kosovo (Kosova/Kosovë / Косово), Montenegro (Црна Гора), Morocco (المغرب), New Zealand (Aotearoa), North Macedonia (Северна Македонија), Norway (Norge), Serbia (Srbija/Сpбија), Switzerland (Schweiz/Suisse/Svizzera), Tunisia (تونس /Tūnis), Türkiye, Ukraine (Україна), United Kingdom |
eligible entities Partners |
Research Institution incl. University, Private institution, incl. private company (private for profit), Public Body (national, regional and local; incl. EGTCs), Education and training institution, Other, Non-Profit Organisation (NPO) / Non-Governmental Organisation (NGO), EU Body, Small and medium-sized enterprise (SME) |
Mandatory partnership | Yes |
Project Partnership | To be eligible for funding, applicants must be established in one of the following countries:
Only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:
Any legal entity, regardless of its place of establishment, including legal entities from non-associated third countries or international organisations (including international European research organisations) is eligible to participate (whether it is eligible for funding or not), provided that the conditions laid down in the Horizon Europe Regulation have been met, along with any other conditions laid down in the specific call topic. A ‘legal entity’ means any natural or legal person created and recognised as such under national law, EU law or international law, which has legal personality and which may, acting in its own name, exercise rights and be subject to obligations, or an entity without legal personality. |
other eligibility criteria | Specific cases:
|
Additional information
Topics | Administration & Governance, Institutional Capacity & Cooperation, Competitiveness of Enterprises, Employment/Labour Market, SME & entrepreneurship, Demographic Change, European Citizenship, Migration, Digitalisation, Digital Society, ICT, Equal Rights, Human Rights, People with Disabilities, Social Inclusion, Health, Social Services, Sports |
Relevance for EU Macro-Region | EUSAIR - EU Strategy for the Adriatic and Ionian Region, EUSALP - EU Strategy for the Alpine Space, EUSBSR - EU Strategy for the Baltic Sea Region, EUSDR - EU Strategy for the Danube Region |
UN Sustainable Development Goals (UN-SDGs) |
![]() ![]() ![]() ![]() ![]() |
Program documents | Horizon Europe Work Programme 2025 Cluster 1 - Health (1200kB) |
Contact | National Contact Points for Horizon Europe Website |
Open calls
22.05.2025 - 16.09.2025
Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
22.05.2025 - 16.09.2025
Advancing knowledge on the impacts of micro- and nanoplastics on human health
22.05.2025 - 16.09.2025
Boosting the translation of biotech research into innovative health therapies
22.05.2025 - 16.09.2025
Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
22.05.2025 - 16.09.2025
Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices
22.05.2025 - 16.09.2025
End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)
22.05.2025 - 16.09.2025
Enhancing cell therapies with genomic techniques
22.05.2025 - 16.09.2025
Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
22.05.2025 - 16.09.2025
Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)
22.05.2025 - 16.09.2025
Improving the quality of life of persons with intellectual disabilities and their families
22.05.2025 - 16.09.2025
Leveraging artificial intelligence for pandemic preparedness and response
22.05.2025 - 16.09.2025
Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
22.05.2025 - 16.09.2025
Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
22.05.2025 - 16.09.2025
Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
22.05.2025 - 16.09.2025
Tackling high-burden for patients and under-researched medical conditions
22.05.2025 - 16.09.2025
Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
22.05.2025 - 16.09.2025
The impact of pollution on the development and progression of brain diseases and disorders
22.05.2025 - 16.09.2025
Geschlossene Calls
30.03.2023 - 19.09.2023
Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes
12.01.2023 - 13.04.2023
Bio-printing of living cells for regenerative medicine
26.10.2023 - 11.04.2024
Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)
12.01.2023 - 13.04.2023
Comparative effectiveness research for healthcare interventions in areas of high public health need
26.04.2023 - 19.09.2023
Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)
26.10.2023 - 11.04.2024
Developing a Data Quality and Utility Label for the European Health Data Space
12.01.2023 - 13.04.2023
Development and harmonisation of methodologies for assessing digital health technologies in Europe
12.01.2023 - 13.04.2023
Environmentally sustainable and climate neutral health and care systems
12.01.2023 - 13.04.2023
European Partnership for Brain Health
13.05.2025 - 03.06.2025
European Partnership on Personalised Medicine
12.01.2023 - 13.04.2023
European Partnership on Rare Diseases
12.01.2023 - 19.09.2023
European Partnership: One Health Anti-Microbial Resistance
26.10.2023 - 11.04.2024
European partnership for pandemic preparedness
25.04.2024 - 26.11.2024
Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
12.01.2023 - 13.04.2023
Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space
12.01.2023 - 13.04.2023
Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators
26.10.2023 - 11.04.2024
Global coordination of exposome research
12.01.2023 - 13.04.2023
Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery
12.01.2023 - 13.04.2023
Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties
12.01.2023 - 13.04.2023
Implementation research for management of multiple long-term conditions in the context of non-communicable diseases (Global Alliance for Chronic Diseases - GACD)
25.04.2024 - 26.11.2024
Innovative non-animal human-based tools and strategies for biomedical research
30.03.2023 - 19.09.2023
Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management
12.01.2023 - 13.04.2023
Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
12.01.2023 - 13.04.2023
Maintaining access to regular health and care services in case of cross-border emergencies
12.01.2023 - 13.04.2023
Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs)
12.01.2023 - 13.04.2023
Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
12.01.2023 - 13.04.2023
Novel approaches for palliative and end-of-life care for non-cancer patients
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness
26.04.2023 - 19.09.2023
Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential
26.10.2023 - 11.04.2024
Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
12.01.2023 - 13.04.2023
Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Maintaining and enhancing the preparatory work for a co-funded European partnership for pandemic preparedness
25.04.2024 - 30.05.2024
Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
26.10.2023 - 11.04.2024
Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks
12.01.2023 - 13.04.2023
Pandemic preparedness and response: Understanding vaccine induced-immunity
12.01.2023 - 13.04.2023
Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources
30.03.2023 - 19.09.2023
Planetary health: understanding the links between environmental degradation and health impacts
12.01.2023 - 13.04.2023
Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
25.04.2024 - 26.11.2024
Relationship between infections and non-communicable diseases
12.01.2023 - 13.04.2023
Resilience and mental wellbeing of the health and care workforce
12.01.2023 - 13.04.2023
Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU
12.01.2023 - 13.04.2023
Tackling high-burden for patients, under-researched medical conditions
26.04.2023 - 19.09.2023
The Silver Deal - Person-centred health and care in European regions
12.01.2023 - 13.04.2023
The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution
30.03.2023 - 19.09.2023
Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society
30.03.2023 - 19.09.2023
Towards structuring brain health research in Europe
12.01.2023 - 13.04.2023
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
26.04.2023 - 19.09.2023